𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progress in the development of new drugs in Alzheimer’s disease

✍ Scribed by Antoine Piau; F. Nourhashémi; C. Hein; C. Caillaud; B. Vellas

Publisher
Springer
Year
2011
Tongue
English
Weight
188 KB
Volume
15
Category
Article
ISSN
1279-7707

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The economic consequences of Alzheimer's
The economic consequences of Alzheimer's disease in the context of new drug developments
✍ Martin Knapp; David Wilkinson; Rachel Wigglesworth 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 165 KB 👁 3 views

The first national symptomatic treatment for Alzheimer's disease has received a very mixed and perhaps ageist reception from purchasers of health care in the UK. This is largely because detailed information on the long-term effects of this class of drugs is scarce. However, by looking at the publish

Cholinergic abnormalities in Alzheimer's
Cholinergic abnormalities in Alzheimer's disease: are there new targets for drug development?
✍ Lisa R. Fodero; David H. Small 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 1 views

## Abstract Alzheimer's disease (AD) is a neurodegenerative disease characterized by cognitive impairment and behavioral changes. Cholinesterase inhibitors are currently the drugs of choice for the treatment of AD. However, alternatives to cholinesterase inhibitors such as muscarinic and nicotinic